News Focus
News Focus
icon url

DewDiligence

10/18/07 4:21 PM

#1791 RE: genisi #1790

I lean more toward the hedge end of the spectrum. In other words, all told I think there’s a bigger risk to Teva from losing the patent than there is from losing market share.